Global Hemostats Market - Forecast (2024 - 2030)
Chapter 1. Hemostats Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Hemostats Market – Executive Summary
2.1. Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2024 - 2030
2.3.2. Impact on Supply – Demand
2.3.3. Impact on Production Cost
2.3.4. Impact on Supply Chain
Chapter 3. Hemostats Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. Hemostats Market Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porters Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. Hemostats Market - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. Hemostats Market – By Type
6.1. Active
6.1.1. Thrombin Based Hemostat
6.1.2. Bovine Thrombin
6.1.3. Pooled Human Plasma Thrombin
6.1.4. Recombinant Thrombin
6.2. Passive
6.2.1. Collagen Based Hemostats
6.2.2. Microfibrillar Collagen Hemostat
6.2.3. Absorbable Collagen Hemostat Sponge
6.2.4. Oxidized Regenerated Cellulose
6.2.5. Gelatins
6.2.6. Polysacchride Hemospheres
6.3. Flowable
6.3.1. Bovine Gelatin + Pooled Human Thrombin
6.3.2. Bovine Gelatin + Other Thrombin Products
6.3.3. Others
6.4. Sealants
6.4.1. Fibrin Sealants
6.4.2. Synthetic Sealants
6.4.3. Others
6.5. Adhesives
6.5.1. Polyethylene Glycol Hydrogels (PEG)
6.5.2. PEG + Trilysine Amine
6.5.3. PEG + Human Serum Albumin
6.5.4. Liquid Monomers
Chapter 7. Hemostats Market - By Treatment
7.1. Cardiac surgery
7.1.2. Vascular procedures
7.1.3. Soft tissue reconstructions
7.1.4. Spinal procedures
7.1.5. Hepatic resection
7.1.6. Others
Chapter 9. Hemostats Market - By Application
9.1. Orthopedic Surgery
9.2. General Surgery
9.3. Neurological Surgery
9.4. Cardiovascular Surgery
9.5. Reconstructive Surgery
9.6. Gynecological Surgery
9.7. Other Surgeries
Chapter 10. Hemostats Market - By End-User
10.1. Hospitals
10.2. Surgery Centres
10.3. Nursing Homes
10.4. Others
Chapter 11. Hemostats Market , By Geography – Market Size, Forecast, Trends & Insights
11.1. North America
11.1.1. U.S.A
11.1.2. Canada
11.1.3. Mexico
11.2. Europe
11.2.1. Italy
11.2.2. Spain
11.2.3. Russia
11.2.4. Germany
11.2.5. UK
11.2.6. France
11.2.7. Rest of Europe
11.3. Asia Pacific
11.3.1. Japan
11.3.2. South Korea
11.3.3. China
11.3.4. India
11.3.5. Australia & New Zealand
11.3.6. Rest of Asia-Pacific
11.4. Rest of the World
11.4.1. Middle East
11.4.2. Africa
11.4.3. South America
Chapter 11. Hemostats Market – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
11.1. Company 1
11.2. Company 2
11.3. Company 3
11.4. Company 4
11.5. Company 5
11.6. Company 6
11.7. Company 7
11.8. Company 8
11.9. Company 9
11.10. Company 10
2850
5250
4500
1800